Cargando…

Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital

BACKGROUND: Carbapenem (CAR) antibiotics have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Unrestricted use can lead to limited susceptibility profiles. Imipenem-cilastatin was also identified as the antipseudomonal β-lactam with the lowest susceptibility to Pseudom...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimata, Stacy, Antczak, Christine, Yu, Phillip S, Trivedi, Kavita K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632079/
http://dx.doi.org/10.1093/ofid/ofx163.599
_version_ 1783269629176578048
author Shimata, Stacy
Antczak, Christine
Yu, Phillip S
Trivedi, Kavita K
author_facet Shimata, Stacy
Antczak, Christine
Yu, Phillip S
Trivedi, Kavita K
author_sort Shimata, Stacy
collection PubMed
description BACKGROUND: Carbapenem (CAR) antibiotics have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Unrestricted use can lead to limited susceptibility profiles. Imipenem-cilastatin was also identified as the antipseudomonal β-lactam with the lowest susceptibility to Pseudomonas aeruginosa (88%) at our 79-bed community hospital. The Antimicrobial Stewardship Committee (ASC) developed an initiative to decrease overall CAR usage by improving prescribing habits and promoting the appropriate use of these antibiotics. METHODS: A CAR Prescribing Algorithm (Figure 1) was developed as guidance to prescribers to promote appropriate CAR use; it was implemented in December 2015. Pharmacists utilized the prospective audit and feedback strategy for new orders that failed to meet the algorithm’s CAR use criteria and recommended alternative therapy when appropriate. A three-part Medication Use Evaluation was conducted to evaluate the impact of implementing the algorithm: Pre-intervention (P1: January to March 2015), Post-intervention (P2: January to March 2016), and six months Post-intervention (P3: July to September 2016). Frequency of appropriate prescribing, antimicrobial days of therapy per 1,000 patient-days (DOT) and cost savings utilizing pharmacy purchasing data were evaluated. RESULTS: In P1, 107 patients received CARs with only 21 (20%) of patients meeting algorithm use criteria. In P2, patients receiving CARs decreased to 31 with 11 (35%) of patients meeting algorithm use criteria. In P3, 27 patients received CARs with 19 (70%) meeting algorithm use criteria. A three-fold decrease in DOT was observed from P1 to P2, 131.8 to 40.2; DOT remained low in P3 at 42.9 (Figure 2). Using 2015 as a baseline, we calculated a $75,000 pharmacy cost saving in 2016 attributed to the CAR Algorithm. CONCLUSION: The implementation of a Pharmacy-driven CAR Prescribing Algorithm at a small community hospital improved prescribing habits and led to a three-fold reduction in overall use. Success with the algorithm continued 6 months after implementation and led to cost-savings for the hospital. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5632079
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56320792017-11-07 Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital Shimata, Stacy Antczak, Christine Yu, Phillip S Trivedi, Kavita K Open Forum Infect Dis Abstracts BACKGROUND: Carbapenem (CAR) antibiotics have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Unrestricted use can lead to limited susceptibility profiles. Imipenem-cilastatin was also identified as the antipseudomonal β-lactam with the lowest susceptibility to Pseudomonas aeruginosa (88%) at our 79-bed community hospital. The Antimicrobial Stewardship Committee (ASC) developed an initiative to decrease overall CAR usage by improving prescribing habits and promoting the appropriate use of these antibiotics. METHODS: A CAR Prescribing Algorithm (Figure 1) was developed as guidance to prescribers to promote appropriate CAR use; it was implemented in December 2015. Pharmacists utilized the prospective audit and feedback strategy for new orders that failed to meet the algorithm’s CAR use criteria and recommended alternative therapy when appropriate. A three-part Medication Use Evaluation was conducted to evaluate the impact of implementing the algorithm: Pre-intervention (P1: January to March 2015), Post-intervention (P2: January to March 2016), and six months Post-intervention (P3: July to September 2016). Frequency of appropriate prescribing, antimicrobial days of therapy per 1,000 patient-days (DOT) and cost savings utilizing pharmacy purchasing data were evaluated. RESULTS: In P1, 107 patients received CARs with only 21 (20%) of patients meeting algorithm use criteria. In P2, patients receiving CARs decreased to 31 with 11 (35%) of patients meeting algorithm use criteria. In P3, 27 patients received CARs with 19 (70%) meeting algorithm use criteria. A three-fold decrease in DOT was observed from P1 to P2, 131.8 to 40.2; DOT remained low in P3 at 42.9 (Figure 2). Using 2015 as a baseline, we calculated a $75,000 pharmacy cost saving in 2016 attributed to the CAR Algorithm. CONCLUSION: The implementation of a Pharmacy-driven CAR Prescribing Algorithm at a small community hospital improved prescribing habits and led to a three-fold reduction in overall use. Success with the algorithm continued 6 months after implementation and led to cost-savings for the hospital. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632079/ http://dx.doi.org/10.1093/ofid/ofx163.599 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Shimata, Stacy
Antczak, Christine
Yu, Phillip S
Trivedi, Kavita K
Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital
title Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital
title_full Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital
title_fullStr Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital
title_full_unstemmed Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital
title_short Implementation of a Carbapenem Prescribing Algorithm at a Community Hospital
title_sort implementation of a carbapenem prescribing algorithm at a community hospital
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632079/
http://dx.doi.org/10.1093/ofid/ofx163.599
work_keys_str_mv AT shimatastacy implementationofacarbapenemprescribingalgorithmatacommunityhospital
AT antczakchristine implementationofacarbapenemprescribingalgorithmatacommunityhospital
AT yuphillips implementationofacarbapenemprescribingalgorithmatacommunityhospital
AT trivedikavitak implementationofacarbapenemprescribingalgorithmatacommunityhospital